Therapeutic Tumor Infiltrating Lymphocytes cell therapy (City of Hope)

N/A

Report date: 2026/04/17 10:36:11

Base Information

Drug NameTherapeutic Tumor Infiltrating Lymphocytes cell therapy (City of Hope)
Drug Alias NameSTIL101
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsPancreatic Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCity Of Hope National Medical Center
Active IndicationsN/A
Inactive IndicationsSolid tumoursUterine Cervical NeoplasmsPancreatic Neoplasms +[10] 

Other Information

ATC CodeN/A
Related LinksN/A